Name: UMIN ID:
Unique ID issued by UMIN | UMIN000042554 |
---|---|
Receipt number | R000048505 |
Scientific Title | A Multi-Center Retrospective Study to Describe Clinical Characteristics and Outcomes of Early EVENITY Users, Transitioning to Antiresorptive Agents in Japan |
Date of disclosure of the study information | 2020/11/26 |
Last modified on | 2022/03/11 10:21:11 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2020/11/25 21:55:49 | ||
2 | Update | 2020/11/26 14:43:52 | Key inclusion criteria |
|
3 | Update | 2021/10/10 19:33:19 | Recruitment status Anticipated trial start date Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
4 | Update | 2021/10/10 19:35:37 | Division name Division name Institute Department Organization Division |
|
5 | Update | 2022/02/09 17:12:35 | Primary outcomes |
|
6 | Update | 2022/03/04 14:32:30 | Number of participants that the trial has enrolled Results Results Results date posted Date of the first journal publication of results Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures Plan to share IPD Plan to share IPD IPD sharing Plan description IPD sharing Plan description |
|
7 | Update | 2022/03/04 14:34:22 | Recruitment status |
|
8 | Update | 2022/03/04 14:35:05 | Publication of results |
|
9 | Update | 2022/03/04 14:39:20 | Results Results |
|
10 | Update | 2022/03/07 16:38:35 | Public title Acronym Scientific Title Scientific Title:Acronym |
|
11 | Update | 2022/03/07 17:00:35 | Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
12 | Update | 2022/03/07 17:13:01 | Condition Narrative objectives1 Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
13 | Update | 2022/03/07 17:41:45 | Last name of lead principal investigator Division name |
|
14 | Update | 2022/03/07 17:46:55 | Results Results |
|
15 | Update | 2022/03/11 10:21:11 | Other related information Other related information |